Medical/Pharmaceuticals
Texas Cardiac Arrhythmia Institute physician led international workshop on cardiac arrhythmias
AUSTIN, Texas, Oct. 26, 2022 /PRNewswire/ -- The executive medical director of theTexas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently ledVenice Arrhythmias 2022, a biennial international workshop on cardiac arrhythmias held inVenice, Italy from October 13 to October 1...
2022-10-26 22:08
4253
OncoK9®, the Pioneering Blood-Based Early Cancer Detection Test for Dogs, Now Available in Asia Through Asia Veterinary Diagnostics
In the first expansion of access beyond North America, the OncoK9® test from PetDx® is now available inHong Kong, Singapore, Malaysia, South Korea, and Cambodia at veterinary clinics served by Asia Veterinary Diagnostics. SAN DIEGO, Oct. 26, 2022 /PRNewswire/ -- PetDx® – The Liquid Biopsy Compan...
2022-10-26 21:00
2464
Lunit Joins World Economic Forum Global Innovators Community
* Lunit invited to join the World Economic Forum's Global Innovators Community, an invitation-only group of the world's most promising start-ups and scale-ups at the forefront of technological and business model innovation * In 2020, Lunit was nominated among hundreds of candidates as one of t...
2022-10-26 21:00
3598
Ascletis Announces U.S. IND Filing of Oral Antiviral ASC10 for Monkeypox Indication
--ASC10 has two indications: monkeypox and SARS-CoV-2 virus infections. The Investigational New Drug (IND) application of the latter was approved by the U.S. Food and Drug Administration (FDA) inAugust 2022 and Phase Ib clinical trial in COVID-19 patients is underway in the U.S. --Preclinical st...
2022-10-26 20:10
3935
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation f...
2022-10-26 19:25
3308
WuXi AppTec Reports Record Year-to-Date Results in 2022, Third Quarter Revenue over RMB10 Billion
Revenue Up 71.9% Year-Over-Year to RMB28,395 Million Net Profit Attributable to Owners of the Company Up 107.1% Year-Over-Year to RMB7,378 Million Diluted Earnings Per Share (EPS) Up 90.1% Year-Over-Year to RMB2.30 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 77.9% Year...
2022-10-26 19:06
4469
Meet the female scientists who develop cellular and gene therapies
SHENZHEN, China, Oct. 26, 2022 /PRNewswire/ -- Inside Namtai Inno Park in Guangming District hides a low-profile biomedical development firm – Shenzhen Wingor Biotechnology Co. Upon entering the company, one may feel a different vibe – something gentle yet vibrant, maybe because it's female-domin...
2022-10-26 17:07
2975
First satellite bioanalytical lab offers fastest option for PBMC processing in Australian clinical trials
THEBARTON, Australia, Oct. 26, 2022 /PRNewswire/ -- On 09 September 2022, Australia welcomed its first bioanalytical laboratory inside a Phase 1 clinical unit. Agilex Biolabs, Australia's largest bioanalytical laboratory, has established its first satellite processing unit on the fifth floor o...
2022-10-26 17:00
1509
Yiling Pharmaceutical Exhibiting its Innovative TCM Products during CHEXPO Macau 2022
SHIJIAZHUANG, China, Oct. 26, 2022 /PRNewswire/ -- CHEXPO Macau 2022 was officially opened onOctober 20, 2022. As one of the top 10 TCM enterprises in China, Yiling Pharmaceutical exhibited a number of its patented TCM and health products during the expo. As an international and frontier city of ...
2022-10-26 16:52
3168
ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round
SHENZHEN, China, Oct. 26, 2022 /PRNewswire/ -- ImmVira announced its successful signing of Series-C+ financing transaction documents with the first batch of investors recently. This round of financing was initiated by China Merchants China Direct Investments Limited with participation of Lifebay ...
2022-10-26 14:26
2964
Mahidol University, the Top University in Thailand, Has Officially Adopted Jolly Good's Medical VR
Developing and Demonstrating VR of Infectious Disease Education in Collaboration with Juntendo University Approximately 15% of All Deaths in Thailand Are Caused by Infectious Diseases TOKYO, Oct. 26, 2022 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to...
2022-10-26 13:00
3751
WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China
- The 11th drug substance facility is released for cGMP operation in the WuXi Biologics' global manufacturing network. This new facility enhances the company's capability of providing commercial manufacturing at 4,000L to 20,000L scale, facilitating any project initiation within four weeks. - ...
2022-10-26 12:30
3122
Singapore to host the 7th World One Health Congress
Leading global scientists and policymakers will exchange learnings to promote multi-sectoral collaboration to address complex global health challenges SINGAPORE, Oct. 26, 2022 /PRNewswire/ -- The 7th World One Health Congress (WOHC), the world's premier event to advance the One Health agenda, wil...
2022-10-26 12:03
3243
Mentice and Acandis GmbH announce a 3-year agreement for Mentice Ankyras clinical support software solutions at a value of 8.9mSEK
Sweden-Gothenburg and Germany-Pforzheim, October 25, 2022 ( https://news.cision.com/mentice-ab). GOTHENBURG, Sweden, Oct. 25, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzh...
2022-10-25 23:23
2621
Alwin Capital's New Dual-Currency Fund Closed and Exceeded Fundraising Target
BEIJING, Oct. 25, 2022 /PRNewswire/ -- Alwin Capital recently closed a new
dual-currency fund, raising overUS$300 million, which exceeds their fundraising
target.
2022-10-25 23:10
3247
Metabolon Advances the Understanding of Inflammation and Inflammatory Response with New Oxysterols Targeted Panel
The new targeted metabolomics panel provides absolute quantitation for important bioactive intermediaries of inflammation and disease pathogenesis MORRISVILLE, N.C., Oct. 25, 2022 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of...
2022-10-25 20:03
2867
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
* CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available for late-stage development. * SK bioscience to secure new vaccines and establish pandemic response system * SK bioscience to enhance human healt...
2022-10-25 20:00
3605
FDA Accepts NMP's Clinical Trial Application for Development of NMK89 as Imaging Agent for Cancer Diagnosis
- Clinical Study Set to Begin, Focusing on Diagnostic Use of Theranostics - TOKYO, Oct. 25, 2022 /PRNewswire/ -- Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company inJapan, is pleased to announce that the U.S. Food and Drug Administration (FDA) has recently accepted NMP's ...
2022-10-25 16:00
2346
Clarivate Identifies Seven Innovators in New RNA Technology Companies to Watch Report
Report analyzes benefits, financing, R&D activity and more to reveal emerging standouts in medical science United States and Mainland China at the forefront of RNA technology advancement LONDON, Oct. 25, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted inform...
2022-10-25 15:19
2371
BioCell Technology Expands Global Presence and Trust with Prestigious Halal Certification
BioCell Collagen®, the company's flagship ingredient, is now halal-certified by the Islamic Information Documentation and Certification GmbH (IIDC), an accreditation accepted in nearly all Islamic countries IRVINE, Calif., Oct. 25, 2022 /PRNewswire/ -- BioCell Collagen®, a clinically-studied die...
2022-10-25 12:00
3652
Week's Top Stories
Most Reposted
OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1141 media titles]
2026-11-05 06:52Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1141 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1105 media titles]
2026-11-09 23:00
Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1083 media titles]
2026-11-03 22:00Most Read
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
26250
ZD Energy Unveils Overseas Smart Energy Solutions in Thailand, Leveraging Local Manufacturing and Scenario-Based Capabilities to Support the Country's Energy Transition
2026-11-06 22:12
15171
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
14653
OceanaGold Reports Third Quarter 2026 Results
2026-11-05 06:52
14453